Quick Answer
GE HealthCare Technologies Inc. reported R&D Expense of $1.26 billion for fiscal year 2025.
GE HealthCare Technologies Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $1.26B | -3.9% |
| 2024 | $1.31B | +8.8% |
| 2023 | $1.21B | +17.4% |
| 2022 | $1.03B | +25.7% |
| 2021 | $816.00M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $292.00M | -7.6% | -3.3% |
| June 30, 2025 | $302.00M | -7.6% | -12.2% |
| March 31, 2025 | $344.00M | +6.2% | +8.9% |
| September 30, 2024 | $316.00M | -1.9% | -3.4% |
| June 30, 2024 | $327.00M | +9.7% | +0.9% |
| March 31, 2024 | $324.00M | +20.0% | +0.6% |
| September 30, 2023 | $322.00M | +23.8% | +8.1% |
| June 30, 2023 | $298.00M | +16.0% | +10.4% |
- GE HealthCare Technologies Inc. showed a decrease of -3.9% in R&D Expense compared to the prior fiscal year.
- Over the 2021–2025 period, GE HealthCare Technologies Inc.’s r&d expense has grown by 54.4% (from $816.00 million to $1.26 billion).
- The most recent figure is from GE HealthCare Technologies Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 4, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: